Showing 141 - 150 of 130,276
Persistent link: https://www.econbiz.de/10009699739
We determine the optimal health policy mix when the average utility of patients increases with the supply of drugs available in a therapeutic class. Health risk coverage rely on two instruments, copayment and reference pricing, that affect the supported risk composed by health expenses and...
Persistent link: https://www.econbiz.de/10009707634
Pricing policy for any experience good faces a key tradeoff. On one hand, a price reduction increases immediate demand and hence more people learn about the product. On the other hand, lower prices may serve as price anchors and, through a comparison effect, decrease subsequent demand. This...
Persistent link: https://www.econbiz.de/10010355764
Persistent link: https://www.econbiz.de/10010363385
This paper studies the effect of pharmaceutical regulation at the wholesale level, if markets are integrated by parallel trade, i.e. trade outside the manufacturerś authorized distribution channel. In particular, maximum wholesale margins, a restriction of pricing by the intermediary, and...
Persistent link: https://www.econbiz.de/10010223101
Persistent link: https://www.econbiz.de/10010224402
Persistent link: https://www.econbiz.de/10010242974
Persistent link: https://www.econbiz.de/10010378606
Persistent link: https://www.econbiz.de/10010381939
Persistent link: https://www.econbiz.de/10010370957